| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
HORMONES AND SIGNALING
University of Calgary, Gastrointestinal Research Group, Calgary, Alberta, Canada, T2T 5C7
Submitted 4 December 2003 ; accepted in final form 7 February 2004
Glucagon-like peptide-2 (GLP-2) is an intestinal trophic enteroendocrine peptide that is associated with intestinal adaptation following resection. Herein, we investigate the effects of GLP-2 in a total parenteral nutrition (TPN)-supported model of experimental short bowel syndrome. Juvenile Sprague-Dawley rats underwent a 90% small intestinal resection and jugular catheter insertion. Rats were randomized to three groups: enteral diet and intravenous saline infusion, TPN only, or TPN + 10 µg·kg–1·h–1 GLP-2. Nutritional maintenance was isocaloric and isonitrogenous. After 7 days, intestinal permeability was assessed by quantifying the urinary recovery of gavaged carbohydrate probes. The following day, animals were euthanized, and intestinal tissue was processed for morphological and crypt cell proliferation (CCP) analysis, apoptosis (caspase-3), and expression of SGLT-1 and GLUT-5 transport proteins. TPN plus GLP-2 treatment resulted in increased bowel and body weight, villus height, intestinal mucosal surface area, CCP, and reduced intestinal permeability compared with the TPN alone animals (P < 0.05). GLP-2 treatment induced increases in serum GLP-2 levels and intestinal SGLT-1 expression (P < 0.01) compared with either TPN or enteral groups. No differences were seen in the villus apoptotic index between resection groups. Enterally fed resected animals had a significant decrease in crypt apoptotic indexes compared with nontreated animals. This study demonstrates that GLP-2 alone, without enteral feeding, stimulates indexes of intestinal adaptation. Secondly, villus hypertrophy associated with adaptation was predominantly due to an increase in CCP and not to changes in apoptotic rates. Further studies are warranted to establish the mechanisms of action and therapeutic potential of GLP-2.
glucagon-like peptide-2; total parenteral nutrition; short bowel syndrome; nutrition; SGLT-1; intestinal adaptation
This article has been cited by other articles:
|
|
 |
|
  M. C. Koopmann, D. W. Nelson, S. G. Murali, X. Liu, M. S. Brownfield, J. J. Holst, and D. M. Ney Exogenous Glucagon-Like Peptide-2 (GLP-2) Augments GLP-2 Receptor mRNA and Maintains Proglucagon mRNA Levels in Resected Rats JPEN J Parenter Enteral Nutr, May 1, 2008; 32(3): 254 - 265. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. W. Nelson, S. G. Murali, X. Liu, M. C. Koopmann, J. J. Holst, and D. M. Ney Insulin-like growth factor I and glucagon-like peptide-2 responses to fasting followed by controlled or ad libitum refeeding in rats Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2008; 294(4): R1175 - R1184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Amin, J. J. Holst, B. Hartmann, L. Wallace, J. Wright, and D. L. Sigalet Functional Ontogeny of the Proglucagon-Derived Peptide Axis in the Premature Human Neonate Pediatrics, January 1, 2008; 121(1): e180 - e186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Sigalet, L. E. Wallace, J. J. Holst, G. R. Martin, T. Kaji, H. Tanaka, and K. A. Sharkey Enteric neural pathways mediate the anti-inflammatory actions of glucagon-like peptide 2 Am J Physiol Gastrointest Liver Physiol, July 1, 2007; 293(1): G211 - G221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Anini, A. Izzo, G. Y. Oudit, P. H. Backx, and P. L. Brubaker Role of phosphatidylinositol-3 kinase-{gamma} in the actions of glucagon-like peptide-2 on the murine small intestine Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1599 - E1606. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Liu, D. W Nelson, J. J Holst, and D. M Ney Synergistic effect of supplemental enteral nutrients and exogenous glucagon-like peptide 2 on intestinal adaptation in a rat model of short bowel syndrome. Am. J. Clinical Nutrition, November 1, 2006; 84(5): 1142 - 1150. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G L Gupte, S V Beath, D A Kelly, A J W Millar, and I W Booth Current issues in the management of intestinal failure. Arch. Dis. Child., March 1, 2006; 91(3): 259 - 264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Kitchen, R. A. Goodlad, A. J. FitzGerald, N. Mandir, M. A. Ghatei, S. R. Bloom, J. Berlanga-Acosta, R. J. Playford, A. Forbes, and J. R.F. Walters Intestinal Growth in Parenterally-Fed Rats Induced by the Combined Effects of Glucagon-like Peptide 2 and Epidermal Growth Factor JPEN J Parenter Enteral Nutr, July 1, 2005; 29(4): 248 - 254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Perez, M. Duxbury, F. G. Rocha, A. P. Ramsanahie, R. S. Farivar, H. Varnholt, H. Ito, H. Wong, J. Rounds, M. J. Zinner, et al. Glucagon-Like Peptide 2 Is an Endogenous Mediator of Postresection Intestinal Adaptation JPEN J Parenter Enteral Nutr, March 1, 2005; 29(2): 97 - 101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. R. Martin, L. E. Wallace, B. Hartmann, J. J. Holst, L. Demchyshyn, K. Toney, and D. L. Sigalet Nutrient-stimulated GLP-2 release and crypt cell proliferation in experimental short bowel syndrome Am J Physiol Gastrointest Liver Physiol, March 1, 2005; 288(3): G431 - G438. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
